1. GlaxoSmithKline Pharma
stock logo

80% Hold

GlaxoSmithKline Pharma Share Price

GLAXO

₹2,430.85-₹42.70 (-1.73%) TodayLast updated on 24 May, 2024 | 03:59 PM IST
₹2,416.10₹2,534.00
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹41,180 Crs

Open

₹2,460.00

Close

₹2,473.55

Circuit range

₹2,968.25 - ₹1,978.85

Day range

₹2,416.10 - ₹2,534.00

Year range

₹1,289.70 - ₹2,534.00

Volume

2,99,355

Avg. traded

₹2,491.05

Revenue (12m)

₹3,454 Crs

GlaxoSmithKline PharmaGlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.

GlaxoSmithKline Pharma Key indicators

arrow

52 week high

₹2,534.00

52 week low

₹1,289.70

P/E ratio

69.79

P/B ratio

21.35

ROE

27.29%

ROCE

37.66%

Dividend yield

1.6%

Debt/Equity ratio

EPS

35.7

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

20%

Hold

80%

Sell

0%

This analysis is based on the reviews of 5 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

25.5%

Net profit margin

17.12%

ROE

27.29%

ROA

15.7%

ROCE

37.66%

Learn more

GlaxoSmithKline Pharma Shareholder returns

arrow

1 day

-1.73%

1 week

+6.29%

1 month

+17.02%

3 months

+11.98%

1 year

+85.61%

3 years

+65.67%

5 years

+89.96%

Revenue statement

All values are in ₹ Crores (Cr)
arrow

Cash flow

All values are in ₹ Crores (Cr)
arrow

Balance sheet

All values are in ₹ Crores (Cr)
arrow

GlaxoSmithKline Pharma Share Price history

arrow
DayOpenCloseDay’s change
Fri, May 24 2024
₹2,460.00
₹2,430.85
-1.73%
Thu, May 23 2024
₹2,381.20
₹2,473.55
+4.33%
Wed, May 22 2024
₹2,357.95
₹2,370.85
+1.13%
Tue, May 21 2024
₹2,358.90
₹2,344.30
-0.65%
Sat, May 18 2024
₹2,385.00
₹2,359.55
+3.17%
Fri, May 17 2024
₹2,036.00
₹2,287.00
+13.08%
Thu, May 16 2024
₹1,999.00
₹2,022.50
+1.68%
Wed, May 15 2024
₹1,999.35
₹1,989.15
-0.27%

Shareholding info

arrow

Promoters (75%)

Mutual Funds (4.51%)

Retail and other (13.62%)

Foreign institutions-FII (3.48%)

Other domestic institutions (3.39%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹32/share

    Ex date 30 Jun 2023

    expand tab
  • Dividend • ₹60/share

    Ex date 07 Jul 2022

    expand tab
  • Dividend • ₹30/share

    Ex date 07 Jul 2022

    expand tab

Learn more

Frequently asked questions